As of Sep 6, 2024, the Mannkind stock's PE ratio is 118.6. This takes into account the latest EPS of $0.05 and stock price of $5.93.
The PE ratio of Mannkind has averaged 44.41 over the last eight years. The current P/E ratio of 118.6 is 167% higher than the historical average. Looking back at the last eight years, MNKD's PE ratio peaked in the Mar 2024 quarter at 113.25, when the price was $4.53 and the EPS was $0.04. The lowest point was in the Jun 2017 quarter, when it reached 1.02 with a price of $1.41 and an EPS of $1.38.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | 2.32 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
MNKD's current PE ratio is higher than the 10-year average.
MNKD's PE ratio stands higher than its peer stocks LLY and MRK.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 21.78 | $298.7B |
HALO Halozyme Therapeutics Inc | 22.69 | $7.5B |
LLY ELI LILLY & Co | 110.76 | $857.96B |
MNKD Mannkind Corp | 118.6 | $1.63B |
NKTR Nektar Therapeutics | N/A | $206.17M |
PFE Pfizer Inc | N/A | $161.84B |
The price to earnings ratio for MNKD stock is 118.6 as of Sep 6, 2024.
The current PE of 118.6 represents the highest historical value in the last eight years.
MNKD's price to earnings ratio is currently 167% above its 8-year historical average.
MNKD's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Sep 6, 2024), Mannkind's share price is $5.93. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.05. Therefore, Mannkind's PE ratio for today is 118.6. PE RATIO(118.6) = STOCK PRICE($5.93) / TTM EPS($0.05)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.